Resultados de la búsqueda 561-570 of 10209 for Cycle

  1. Oncología (médica) - Ensayos clínicos

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  2. Ensayos clínicos - Neurología

    The purpose of this study is to assess the safety, tolerability, and effectiveness of additional 6-week treatment cycles with Rozanolixizumab in study ...

  3. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  4. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  5. Oncología (médica) - Ensayos clínicos

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...

  6. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  7. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these cystic kidney ...

  8. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  9. Oncología (médica) - Ensayos clínicos

    ... cycles of mosunetuzumab. An additional arm (open to non-US participants only) has been added to assess the safety, tolerability, pharmacokinetics, and ...

  10. Oncología (médica) - Ensayos clínicos

    All participants who have completed the first course of pembrolizumab may be eligible for up to an additional 9 cycles of pembrolizumab monotherapy if there ...